SCHEMBL624528

SCHEMBL624528

CC(C)(C)OC(=O)N1CCC2(CCCN(c3nn4cc(-c5cccc(OC(F)(F)F)c5)nc4s3)C2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.41
USP2 O75604 4/20 0.41
TSHR P16473 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
THRB P10828 2/20 0.40
RET P07949 2/20 0.40
MAPT P10636 5/20 0.40
HSD17B10 Q99714 3/20 0.40
ALDH1A1 P00352 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HCRTR1 O43613 3/20 0.38
HCRTR2 O43614 3/20 0.38
RXFP1 Q9HBX9 1/20 0.38
SCD5 Q86SK9 1/20 0.38
CYP1A2 P05177 3/20 0.38
CYP2C9 P11712 3/20 0.38
HIF1A Q16665 2/20 0.38
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL623996 0.96 THRB (0.42) THRBRETMAPTHCRTR1HCRTR2
SCHEMBL625512 0.92 THRB (0.44) THRBMAPTRXFP1SCD5CYP11B2
SCHEMBL624527 0.86 PIM1 (0.43) CYP3A4USP2TSHRMEN1KMT2A
SCHEMBL625496 0.82 PIM1 (0.39) THRBMAPTHSD17B10ALDH1A1HCRTR1
SCHEMBL625742 0.82 THRB (0.43) THRBMAPTRXFP1
SCHEMBL623995 0.82 PIM1 (0.44) RETCYP11B2
SCHEMBL623207 0.81 PIM1 (0.48) THRBMAPTHCRTR1HCRTR2RXFP1
SCHEMBL626123 0.81 RET (0.43) RET
SCHEMBL624454 0.79 PIM1 (0.45) RET
SCHEMBL627422 0.79 RET (0.42) CYP3A4USP2TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020217-A1 AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-02-16 WO disclosed